Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Peglasp 3750IU Injection
Manufacturer/Marketed By : METTA LIFE SCIENCES PVT LTD
$365.24 $211.84
Sidmex Inovia offers bulk export supply of Peglasp 3750IU Injection (PEG L-ASPARAGINASE) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and...
PEG L-ASPARAGINASE
Active Pharmaceutical Ingredient
Peglasp 3750IU Injection
$365.24
$211.84
Sidmex Inovia offers bulk export supply of Peglasp 3750IU Injection (PEG L-ASPARAGINASE) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Peglasp 3750IU Injection contains Peg-L-asparaginase. It is used to treat Acute Lymphoblastic Leukemia (cancer of white blood cells) in patients aged four months and above. In Acute Lymphoblastic Leukemia, the white blood cells called lymphocytes multiply uncontrolled and abnormally. This disorder is also known as Acute Lymphocytic Leukemia. This medicine should not be used if you have severe problems with your pancreas or are allergic to asparaginase or any of the ingredients of this medicine. Talk to your physician if you are a diabetic patient, as this medicine contains glucose. The common side effects of Peglasp 3750IU Injection are muscle pain, nausea, infections, abdominal pain, and diarrhoea. Use effective birth control during the treatment with Peglasp 3750IU Injection and for at least three months after the last dose. Women should use contraception methods other than oral contraceptives.
Active Pharmaceutical Ingredient
Uses
• Acute Lymphoblastic Leukemia (ALL)
Benefits
Cancer cells need a substance called asparagine to survive. Peglasp 3750IU Injection works by lowering the levels of asparagine in the body.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Most Common Side Effects
• Nausea
• Muscle pain
• Weight loss
• Infections (fever, rapid heart rate, confusion, or a rash)
• Difficulty breathing
• Inflammation of the digestive tract
• Diarrhea
• Abdominal pain, discomfort
• Headache
• Tiredness
Common Side Effects
• Severe allergic reactions
• High blood sugar levels
• Bleeding
• Liver and nervous problems
• Pain near your stomach (inflammation of the pancreas)
• Blood clots in arm or leg
• Pain, bruising, swelling, or hardening of the skin at the injection site
How To Use
It will be given to you by your healthcare professional. Your doctor will decide the dose and dosage of your treatment based on the disease condition and other factors. Do not self-administer.
Safety Advice
• Breast Feeding: You must not breastfeed your baby during treatment with Peglasp 3750IU Injection. You need to tell your physician if you are breastfeeding before taking this medicine.
• Alcohol: It is unknown whether it is safe to consume alcohol while taking Peglasp 3750IU Injection. Inform your physician if you are a chronic drinker.
• Liver: You need to tell your physician if you have any liver disorders before taking Peglasp 3750IU Injection.
• Lungs: Limited information is available on the safety of Peglasp 3750IU Injection in patients with lung problems. Inform your physician if you have lung disease or disorders before initiating the treatment.
• Driving: Peglasp 3750IU Injection can cause dizziness and drowsiness. Avoid driving if you are unwell.
• Pregnancy: You should not take Peglasp 3750IU Injection if you are pregnant or planning to get pregnant because it may cause birth defects.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.